Indications |
Oral Giardiasis, Cholera Adult: 100 mg 4 times daily. Usual duration: 2-5 days, up to 7 days in some patients or 10 days for giardiasis. Child: 1.25 mg/kg 4 times daily, usually given for 2-5 days or up to 10 days for giardiasis. |
Contraindications |
Hypersensitivity, infants <1 mth. Alcohol. |
Warnings / Precautions |
Pregnancy, lactation, G6PD deficiency. |
Adverse Reactions |
Hypersensitivity, hypoglycaemia, orthostatic hypotension, dizziness, drowsiness, headache, malaise, nausea, vomiting, rash, fever, arthralgia, brown urine, haemolytic anaemia. Potentially Fatal: Agranulocytosis. Hypertensive crisis with MAOIs. |
Drug Interactions |
Disulfiram-like reaction with alcohol. Potential hypertensive crisis with sympathomimetics, tyramine-containing foods, levodopa. Potentially Fatal: Potentiation of MAOIs. Toxic psychosis with amitriptyline. See Below for More furazolidone Drug Interactions |
Food Interactions |
Reaction with foods rich in tyramine. |
Mechanism of Actions |
Furazolidone has a broad antibacterial spectrum which is active against susceptible organisms including E. coli, staphylococci, Giardia sp. and against salmonella, shigella, proteus, and V. cholerae. Its bactericidal action is by interfering with bacterial enzyme systems. Absorption: Poor (oral). Excretion: Urine (as active drug and metabolites). |
Administration |
Should be taken with food. (Avoid food & beverage containing tyramine or tryptophan, eg alcohol, beer (incl alcohol-free beer), cheese, yoghurt. See lit for complete list.) |
ATC Classification |
G01AX06 - furazolidone ; Belongs to the class of other antiinfectives and antiseptics. Used in the treatment of gynecological infections. |
Available As |
|
Furazolidone
Post Review about Furazolidone Click here to cancel reply.
Furazolidone Containing Brands
Furazolidone is used in following diseases
Drug - Drug Interactions of Furazolidone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.